Wednesday, August 16, 2017 7:01:45 PM
DUBLIN, August 16, 2017 /PRNewswire/ --
The "Software-Defined Networking and Network Function Virtualization Market by Component (Solution (Software (Controller, and Application Software), Physical Appliances), and Service), End-User, and Region - Global forecast to 2022" report has been added to Research and Markets' offering.
The Software-Defined Networking (SDN) and Network Functions Virtualization (NFV) market is expected to grow from USD 3.68 Billion in 2017 to USD 54.41 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 71.4%.
The main driving factors for the Software Defined Networking Market are the increasing evolution and demand in mobility, the increased network complexity and varied traffic pattern, and the surge in demand for cloud service, data center consolidation, and server virtualization.
The SDN and NFV is gaining prominence due to the growing technological advancements in networking and data center consolidation. SDN is a ground-breaking networking architecture, which is poised to entirely revolutionize the existing networking and data center infrastructure. The SDN architectural framework is set to redefine the networking infrastructure to meet the growing number of network users consuming a high bandwidth. With a decoupled control plane that can be complimented with various Artificial Intelligence (AI)-based software tools, a lucid improvisation to the traditionally distributed control plane is feasible, enabling an intelligent and efficient network.
The controllers provide a centralized interface to manage the complete network, whereas the application software enables the service providers to perform various functions, such as Virtual Private Networks (VPNs), Network Address Translation (NAT), load balancing, and security, at the service edge itself. It acts as a bridge between the physical infrastructure and software solutions.
http://www.prnewswire.com/news-releases/50-billion-software-defined-networking-and-network-function-virtualization-market-2017---global-forecast-to-2022-300505209.html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM